Tatva Chintan Pharma Chem Share Price

₹ 1,677.80

+₹40.70 (2.49%)
1D
Last updated 04 Nov, 2026, 14:01 IST
NSE: TATVA
|
Chemicals

Tatva Chintan Pharma Chem Share Price Today

As of 4 Nov 2026, Tatva Chintan Pharma Chem share price is ₹1,677.80. The stock opened at ₹1,640.00, compared to its previous close of ₹1,637.10. During today's trading session, Tatva Chintan Pharma Chem share price moved in the range of ₹1,611.10 to ₹1,679.80, with an average price of ₹1,645.45 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,044.10 and a high of ₹2,113.60. On the performance front, Tatva Chintan Pharma Chem share price has increased by 24.87% over the last six months and is up 15.88% on a year-on-year basis.

Share price over the last 1 day rose from 1624.10 to 1679.80, ranging between 1612.40 and 1679.80.
₹1,611.10
2.49% up today
₹1,679.80
1D LOW
1D HIGH

Tatva Chintan Pharma Chem Stock Insights

Latest Earning
Op Profit TrendUp by 37.09% QoQ
Latest Earning
Net Profit TrendUp by 34.23% QoQ
Latest Earning
Revenue TrendUp by 28.99% QoQ
Stock Performance
OutperformingBeat Nifty by 22.29 % in last 6 month
Shareholding Pattern
DIIDII increased stake by 6.89%
Shareholding Pattern
FIIFII increased stake by 11.35%
Tatva Chintan Pharma Chem stock performance
Open₹1,640.00
High₹1,679.80
Low₹1,611.10
Prev. close₹1,637.10
Tatva Chintan Pharma Chem trading activity
Volume30,473
Average traded price₹1,647.07
Last traded time02:01:04 04 Nov
Last traded quantity4
Circuit
L
H
₹1,309.70
₹1,964.50
52-week
L
H
₹1,044.10
₹2,113.60
Mkt Cap Cr
3,884.02
P/E
60.84
P/B
4.7
ROA
5.62%
ROE
7.72%
ROCE
9.23%
Quick Ratio
0.72
EV/EBITDA
30.81

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Tatva Chintan has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Tatva Chintan appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Tatva Chintan revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Pidilite Industries1,51,253.2255.6613.4916.75%23.94%31.93%1.936.42
SRF71,141.9631.34.678.83%14.92%14.86%0.6819.02
Linde India49,132.7991.311.698.07%12.87%17.16%0.7649.7
Gujarat Fluorochemicals48,887.0979.146.085.05%7.13%8.93%0.9735.15
Navin Fluorine43,786.5048.099.8113.33%20.41%22.03%2.1930.09
Godrej Industries31,375.9914.522.871.75%11.1%9.34%0.3512.2
Himadri Speciality Chemicals26,255.5231.065.212.32%16.65%19.3%1.6720.72
Deepak Nitrite20,842.2219.623.2210.83%16.4%18.59%1.7312.55
Aether Industries21,507.9679.977.696.92%9.61%10.65%0.9648.88
Castrol India19,441.2018.7510.0646.22%46.94%71.77%1.2812.07

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Tatva Chintan Pharma Chem Company Background

ISIN
INE0GK401011
Sector Market Cap
₹ 3,884.02 Cr

Tatva Chintan Pharma Chem Limited is an India-based specialty chemical manufacturing company. The Company is engaged in the manufacturing of a variety of chemicals, including structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts and solutions (ESS) for capacitor batteries, and pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC). Its SDAs are used for forming channels in zeolites. Its PTCs are used in heterogeneous multiphase systems, facilitating reactant migration. It operates through the Specialty chemical segment. The Company operates two manufacturing facilities situated at Ankleshwar and Dahej in Bharuch, Gujarat, India. It caters to various customers across various industries, including the automotive, refinery, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care, and flavors and fragrances industries. The Company’s subsidiaries are Tatva Chintan Europe B.V. and Tatva Chintan USA Inc.

Tatva Chintan Pharma Chem Financial Highlights

  • Revenue: Tatva Chintan Pharma Chem reported revenue of ₹509.41 crore in FY26 vs ₹385.03 crore in FY25. It showed an increase of 32.30% on a yearly basis.
  • Operating Profit: Tatva Chintan Pharma Chem reported an operating profit of ₹57.01 crore in FY26 vs ₹7.58 crore in FY25. It showed an increase of 652.11% on a year-on-year basis.
  • Net Profit: Tatva Chintan Pharma Chem reported a net profit of ₹42.05 crore in FY26 vs ₹5.71 crore in FY25. It showed an increase of 636.43% on a yearly basis.

Tatva Chintan Pharma Chem Quarterly Result Highlights

  • Tatva Chintan Pharma Chem reported revenue of ₹219.07 crore in Sep 2026, compared with ₹169.84 crore in Jun 2026, representing an increase of 28.99% on a quarter-on-quarter (QoQ) basis.
  • Tatva Chintan Pharma Chem reported an operating profit of ₹28.94 crore in Sep 2026, compared with ₹21.11 crore in Jun 2026, representing an increase of 37.09% on a quarter-on-quarter (QoQ) basis.
  • Tatva Chintan Pharma Chem reported a profit of ₹21.45 crore in Sep 2026, compared with ₹15.98 crore in Jun 2026, reflecting an increase of 34.23% on a QoQ basis.
  • The earnings per share (EPS) of Tatva Chintan Pharma Chem stood at ₹17.98 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
72.02%
FII
4.38%
Other DII
0.34%
Retail and other
20.39%
Mutual funds
2.87%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20254.17%
Mar 20263.82%
Jun 20263.93%
Sep 20264.38%

Tatva Chintan Pharma Chem Investment Returns

1 day
-1.49%
1 week
+1.97%
1 month
-6.09%
1 year
+15.88%
3 years
+15.05%
5 years
-41.09%

Tatva Chintan Pharma Chem Share Price History

Tatva Chintan Pharma Chem share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
03 Nov 26
₹1,668.00 / ₹1,637.10
-1.49%
02 Nov 26
₹1,645.00 / ₹1,661.80
+1.09%
30 Oct 26
₹1,624.90 / ₹1,643.90
+1.80%
29 Oct 26
₹1,637.00 / ₹1,614.80
-0.80%
Show more

Tatva Chintan Pharma Chem Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹505.86₹382.71₹393.50₹423.61
Other Income₹3.55₹2.32₹7.51₹5.74
Total Revenue₹509.41₹385.03₹401.01₹429.36
Total Expenses₹452.40₹377.45₹357.45₹380.99
Profit Before Tax₹57.01₹7.58₹43.57₹44.78
Tax₹14.96₹1.87₹13.21-₹0.71
Profit After Tax₹42.05₹5.71₹30.35₹45.49
EPS - Basic₹17.98₹2.44₹13.26₹20.52
EPS - Diluted₹17.98₹2.44₹13.26₹20.52

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹57.01₹7.58₹43.57₹44.78
Income before WC changes₹101.09₹36.89₹72.17₹61.47
Change in Assets-₹87.03-₹2.76₹22.02-₹4.31
Change in Liabilities₹25.10-₹4.85₹12.42-₹20.09
Change in WC-₹61.93-₹7.62₹34.44-₹24.40
Cash flow from Operations₹31.49₹24.77₹98.04₹27.78
Cash flow from Investing-₹115.84-₹65.38-₹120.54-₹101.14
Cash flow from Financing₹78.93₹16.59₹30.52₹37.80
Total Cash Flow-₹5.42-₹24.02₹8.02-₹35.57
Cash (Start of the year)₹11.37₹35.30₹27.37₹63.02
Cash (End of the year)₹5.76₹11.37₹35.30₹27.37

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹654.18₹571.00₹520.81₹446.61
Current Assets₹349.51₹265.25₹297.91₹312.25
Total Assets₹1,003.69₹836.25₹818.72₹758.86
Current Liabilities₹213.14₹96.03₹79.66₹238.69
Net Current Asset₹136.38₹169.22₹218.24₹73.56
Non-Current Liabilities₹8.80₹1.40₹1.97₹5.38
Equity Capital₹781.76₹738.82₹737.08₹514.79
Total Equity & Liabilities₹1,003.69₹836.25₹818.72₹758.86

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹496.30₹366.42₹378.68₹403.04
Other Income₹3.53₹3.56₹7.51₹5.68
Total Revenue₹499.82₹369.98₹386.19₹408.72
Total Expenses₹446.66₹369.52₹343.92₹366.30
Profit Before Tax₹53.17₹0.46₹42.27₹38.83
Tax₹14.08₹0.13₹12.92-₹1.63
Profit After Tax₹39.08₹0.33₹29.35₹40.47
EPS - Basic₹16.71₹0.14₹12.82₹18.26
EPS - Diluted₹16.71₹0.14₹12.82₹18.26

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹53.17₹0.46₹42.27₹38.83
Income before WC changes₹94.46₹28.80₹70.44₹54.65
Change in Assets-₹96.15₹6.47₹24.54₹14.02
Change in Liabilities₹35.10-₹6.83₹14.27-₹37.20
Change in WC-₹61.06-₹0.35₹38.81-₹23.18
Cash flow from Operations₹29.17₹24.01₹102.78₹23.73
Cash flow from Investing-₹115.83-₹65.38-₹120.54-₹101.12
Cash flow from Financing₹78.93₹16.59₹30.54₹37.82
Total Cash Flow-₹7.74-₹24.78₹12.78-₹39.58
Cash (Start of the year)₹9.21₹33.99₹21.19₹60.78
Cash (End of the year)₹1.47₹9.21₹33.99₹21.19

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹653.43₹571.29₹521.46₹447.25
Current Assets₹341.95₹251.52₹293.61₹307.61
Total Assets₹995.38₹822.80₹815.07₹754.86
Current Liabilities₹228.35₹100.09₹87.21₹244.70
Net Current Asset₹113.60₹151.43₹206.39₹62.91
Non-Current Liabilities₹8.80₹1.40₹1.97₹5.38
Equity Capital₹758.23₹721.31₹725.88₹504.78
Total Equity & Liabilities₹995.38₹822.80₹815.07₹754.86
* All values are in INR Crore
Tatva Chintan Pharma Chem market depth
Bid quantityBid priceAsk priceAsk quantity
11677.41679.87
21677.31679.916
21677.2168077
81677.11680.210
1416771680.72
Total bid quantity27
Total ask quantity112
Tatva Chintan Pharma Chem technical summary
Bearish indicators1
Neutral indicators5
Bullish indicators2
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
42.63
Neutral
ATR (14)
119.29
Neutral
STOCH(9,6)
35.09
Neutral
STOCH RSI (14)
26.25
Neutral
ADX(9)
17.18
Bullish
UO(9)
51.84
Neutral
ROC(12)
-15.64
Bearish
WillR(14)
-81.02
Bullish
Period
Simple value
Exponential vaue
5D
1637.08
1643.33
10D
1648.18
1671.72
20D
1772.6
1713.78
50D
1718.36
1705.32
100D
1596.61
1614.32
Volume trend — traded volume by day
4 Nov0L
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Tatva Chintan Pharma Chem
Chemicals
Add Stock
Add Another

Tatva Chintan Pharma Chem Returns Calculator

Ex-date: 11 Sep 2026

Top Gainers

SAREGAMA Share Price
₹641.70
+79.5 (+14.14%)
GMDCLTD Share Price
₹466.55
+40.95 (+9.62%)
LINDEINDIA Share Price
₹6331.00
+482.5 (+8.25%)
REDINGTON Share Price
₹362.50
+27.25 (+8.13%)
MUTHOOTFIN Share Price
₹2718.90
+190.7 (+7.54%)
See more

Top Losers

SKFINDIA Share Price
₹1398.00
-73.9 (-5.02%)
AIAENG Share Price
₹3225.50
-164.2 (-4.84%)
ALKYLAMINE Share Price
₹1588.60
-70.2 (-4.23%)
ASAHIINDIA Share Price
₹957.85
-33.6 (-3.39%)
MPHASIS Share Price
₹2457.40
-77.9 (-3.07%)
See more

Tatva Chintan Pharma Chem Share Price FAQs

Please be aware that Tatva Chintan Pharma Chem stock prices are subject to continuous fluctuations due to various factors.